Biomarkers of breast hyperplasias and in situ carcinomas: an overview.

P. J. van Diest, J. P. Baak

Research output: Contribution to journalArticlepeer-review

Abstract

Hyperplasia and carcinoma in situ of the breast are thought to be non-obligatory precursor lesions of invasive breast carcinoma. Such lesions are detected more and more through mammography. A subjective, clinically relevant histopathological classification system of preinvasive breast lesions has been established by Page and co-workers in large groups of patients with long term follow-up. Attempts have been made to objectify the changes within the different preinvasive entities using quantitative techniques. Furthermore, some clues have been found as to the molecular background of breast oncogenesis. In this paper, an overview of possible surrogate endpoint biomarkers of breast hyperplasia and carcinoma in situ is presented.

Original languageEnglish (US)
Pages (from-to)99-104
Number of pages6
JournalJournal of cellular biochemistry. Supplement
Volume19
StatePublished - 1994
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry
  • Cell Biology

Fingerprint

Dive into the research topics of 'Biomarkers of breast hyperplasias and in situ carcinomas: an overview.'. Together they form a unique fingerprint.

Cite this